Elite Pharmaceuticals GAAP EPS of -$0.01, revenue of $40.2M
Source: SeekingAlpha
2025-08-14 23:48:50 ET
More on Elite Pharmaceuticals
- Elite Pharmaceuticals, Inc. (ELTP) Q4 2025 Earnings Call Transcript
- Financial information for Elite Pharmaceuticals
Read the full article on Seeking Alpha
For further details see:
Elite Pharmaceuticals GAAP EPS of -$0.01, revenue of $40.2M
Elite Pharmaceuticals Inc.
NASDAQ: ELTP
ELTP Trading
0.53% G/L:
$0.3951 Last:
471,095 Volume:
$0.3975 Open:
ELTP Latest News
February 17, 2026 04:19:00 pm
Elite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year 2026 (three months ended December 31, 2025) and Provides Conference Call Information
February 11, 2026 04:30:00 pm
Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Third Quarter 2026 Financial Results on February 18, 2026
ELTP Stock Data
$453,759,839
743,518,083
0.33%
2
757074%
Pharmaceuticals
Healthcare
US
Northvale
